Boston, MA, United States of America

Adem Koksal

This inventor holds 1 USPTO granted patent. Top assignee: Children's Medical Center Corporation. Active years: 2017.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Adem Koksal: Innovator in Immunology

Introduction

Adem Koksal is a notable inventor based in Boston, MA. He has made significant contributions to the field of immunology, particularly in the development of innovative solutions for combating parasitic infections. His work is characterized by a commitment to advancing medical science and improving health outcomes.

Latest Patents

Adem Koksal holds a patent for "Conformation-stabilized TRAP antigens." This invention relates to compositions and methods for eliciting an immune response against a parasite of the genus in a mammal. His innovative approach aims to enhance the effectiveness of immune responses, which is crucial for developing new therapeutic strategies.

Career Highlights

Koksal is affiliated with the Children's Medical Center Corporation, where he applies his expertise in immunology to advance research and development. His work at this institution underscores his dedication to improving pediatric health through innovative medical solutions.

Collaborations

Throughout his career, Adem Koksal has collaborated with esteemed colleagues, including Gaojie Song and Chafen Lu. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in the field of immunology.

Conclusion

Adem Koksal's contributions to immunology through his patent and work at the Children's Medical Center Corporation highlight his role as an innovator in the medical field. His dedication to advancing health solutions is commendable and reflects the importance of innovation in addressing global health challenges.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…